Drug reviewers in regulatory authorities (health authorities) around the world have the responsibility of evaluating safety, effectiveness and quality control data for a new drug before it is approved for marketing. The regulatory requirements, structure and processes of various regulatory authorities are different, making it

中文翻译：

---

监管观察：国际监管机构的结构和程序特征

全球监管机构（卫生当局）中的药品审查人员都有责任在批准新药上市之前评估其安全性，有效性和质量控制数据。各个监管机构的监管要求，结构和流程都不尽相同，